Disc Medicine (IRON) Stock Forecast & Price Target

IRON$80.00-3.23 -3.88%
BiotechnologyGrowth Stock
Compare
Market cap$3.07BEnterprise value$3.31BRevenue (TTM)$0Market position—

Score

66
Bullish
Value
52
Quality
47
Growth
98

Disc Medicine, Inc. price target

IRON
Low$92.00
Average$127.14
High$170.00
Upside vs current price+58.9%

The average target of $127.14 is +58.9% versus the current IRON price of $80.00.

Disc Medicine, Inc. analyst ratings

RatingAnalysts
Strong buy1
Buy12
Hold0
Sell0
Strong sell0
ConsensusBuy

13 analysts cover IRON.

Disc Medicine, Inc. EPS and revenue estimates

IRON shows the next fiscal years with at least three analysts: 2026 EPS $-6.31, 2027 EPS $-6.63. A thinner year is left off this table.

Fiscal yearEPS estimateRevenue estimate
2026$-6.31$3.16M
2027$-6.63$32.65M

Is Disc Medicine, Inc. a buy or sell?

Of the 13 analysts covering Disc Medicine, Inc., 13 rate it a buy (1 strong buy and 12 buy), 0 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).

The IRON consensus label is Buy, beside 13 buy-side ratings and 0 sell-side ratings.

The average target of $127.14 implies +58.9% versus the current price of $80.00.

Those 13 ratings on IRON are a headcount, and the label on file is Buy.

Reading the Disc Medicine, Inc. forecast

The IRON target range is wide: $92.00 at the low end, $127.14 in the middle, and $170.00 at the top.

Set next to the $80.00 IRON quote, that average is +58.9%.

Ratings on the Disc Medicine, Inc. cluster: 13 of 13 analysts are on the buy side, 0 are at hold, and 0 are on the sell side, and the published consensus is Buy.

The average IRON target over the last month is $128.33, above the $119.40 average of the last quarter.

Only 13 analysts cover IRON, so the average rests on a short list.

Disc Medicine, Inc. forecast questions

What is the IRON price target?

The published range for IRON is $92.00 to $170.00, with an average of $127.14. That average is +58.9% versus the current price of $80.00.

Is Disc Medicine, Inc. a buy or sell?

Of the 13 analysts covering Disc Medicine, Inc., 13 rate it a buy, 0 rate it a hold, and 0 rate it a sell. The consensus is Buy, and the IRON headcount is 13 buy, 0 hold, and 0 sell.

What is the EPS estimate for Disc Medicine, Inc.?

Analyst EPS estimates for Disc Medicine, Inc.: 2026 $-6.31, 2027 $-6.63.

What is the revenue estimate for Disc Medicine, Inc.?

Analyst revenue estimates for Disc Medicine, Inc.: 2026 $3.16M, 2027 $32.65M.

How many analysts cover IRON?

13 analysts cover IRON. Their consensus on IRON is Buy, across those 13.

IRON price $80.00 -3.23 -3.88%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener